Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach

被引:28
|
作者
Karim, Roksana [1 ,2 ]
Mack, Wendy J. [2 ]
Stiller, Tracey [3 ]
Operskalski, Eva [1 ]
Frederick, Toni [1 ]
Landay, Alan [4 ]
Young, Mary A. [5 ]
Tien, Phyllis C. [6 ,7 ]
Augenbraun, Mike [8 ]
Strickler, Howard D. [9 ]
Kovacs, Andrea [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Ctr Infect Dis & Virol, Dept Pediat Maternal Child & Adolescent, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
[3] City Hope Natl Med Ctr, Dept Biostat, Duarte, CA 91010 USA
[4] Rush Univ, Dept Immunol Microbiol, Med Ctr, Chicago, IL 60612 USA
[5] Georgetown Univ, Div Infect Dis, Washington, DC USA
[6] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[7] Vet Affair Med Ctr, San Francisco, CA USA
[8] SUNY Downstate Coll Med, Dept Med, Brooklyn, NY USA
[9] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
关键词
AIDS; cluster analysis; immune activation; IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL-ACTIVATION; ACTIVE ANTIRETROVIRAL THERAPY; CD38; ANTIGEN-EXPRESSION; LYMPHOCYTE-ACTIVATION; INFECTED PATIENTS; I INFECTION; HLA-DR; CD4(+); CD8(+);
D O I
10.1097/QAD.0b013e3283601bad
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: CD4 and CD8 T-cell activation are independent predictors of AIDS. The complete activation profile of both T-cell subtypes and their predictive value for AIDS risk is largely unknown. Design: A total of 564 AIDS-free women in the Women's Interagency HIV Study were followed over 6.1 years (median) after T-cell activation assessment. A cluster analysis approach was used to evaluate the concurrent activation patterns of CD4 and CD8 T cells at the beginning of follow-up in relation to AIDS progression. Methods: Percentages of CD4 and CD8 T cells with HLA-DR +/- and CD38 +/- were assessed by flowcytometry. Eight immunologic variables (four on each CD4(+) and CD8(+): DR +/- and CD38 +/-) were assessed to yield a 4-cluster solution on samples obtained before clinical endpoints. Proportional hazards survival regression estimated relative risks for AIDS progression by cluster membership. Results: Compared with the other three clusters, outstanding activation features of each distinct cluster of women were: Cluster 1: higher CD8(+)CD38(-)DR(-) (average = 41% of total CD8 T-cell pool), CD4(+)CD38(-)DR(-) (average 53% of total CD4 T-cell pool), and CD8(+)CD38(-)DR(+) (28%); Cluster 2: higher CD8(+)CD38(+)DR(-) (44%) and CD4(+)CD38(+)DR(-) (58%); Cluster 3: higher CD8(+)CD38(+)DR(+) (49%) and CD4(+) CD38(+)DR(-) (48%); Cluster 4: higher CD8(+)CD38(+)DR(+) (49%), CD4(+)CD38(+)DR(+) (36%) and CD4(+)CD38(-) DR+ (19%). Compared with cluster 1, women in cluster 4 had two-fold increased risk of AIDS progression (Hazard ratio 2.13; 95% confidence interval 1.30-3.50) adjusted for CD4 cell count, HIV RNA, and other confounders. Conclusion: A profile including CD4 and CD8 T-cell activation provided insight into HIV pathogenesis indicating concurrent hyperactivation of CD4 and CD8 T cells is associated with AIDS progression. (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:1473 / 1481
页数:9
相关论文
共 50 条
  • [21] Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression
    Hardy, Gareth A. D.
    Sieg, Scott F.
    Rodriguez, Benigno
    Jiang, Wei
    Asaad, Robert
    Lederman, Michael M.
    Harding, Clifford V.
    BLOOD, 2009, 113 (22) : 5497 - 5505
  • [22] Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection
    Mildvan, D
    Spritzler, J
    Grossberg, SE
    Fahey, JL
    Johnston, DM
    Schock, BR
    Kagan, J
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (06) : 853 - 858
  • [23] The trajectory of immune development in early life and its association with clinical allergic disease outcomes
    Gamez, C.
    Leffler, J.
    Prescott, S. L.
    Strickland, D.
    Palmer, D. J.
    Rueter, K.
    ALLERGY, 2021, 76 : 18 - 18
  • [24] Heroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort
    Edelman, E. Jennifer
    Cheng, Debbie M.
    Krupitsky, Evgeny M.
    Bridden, Carly
    Quinn, Emily
    Walley, Alexander Y.
    Lioznov, Dmitry A.
    Blokhina, Elena
    Zvartau, Edwin
    Samet, Jeffrey H.
    AIDS AND BEHAVIOR, 2015, 19 (06) : 1089 - 1097
  • [25] Heroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort
    E. Jennifer Edelman
    Debbie M. Cheng
    Evgeny M. Krupitsky
    Carly Bridden
    Emily Quinn
    Alexander Y. Walley
    Dmitry A. Lioznov
    Elena Blokhina
    Edwin Zvartau
    Jeffrey H. Samet
    AIDS and Behavior, 2015, 19 : 1089 - 1097
  • [26] Early Immune Activation Predicts Central Nervous System Disease in HIV-Infected Infants: Implications for Early Treatment
    Kovacs, Andrea
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (03) : 347 - 349
  • [27] Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating
    Schuepbach, W. M. M.
    Corvol, J-C
    Czernecki, V.
    Djebara, M. B.
    Golmard, J-L
    Agid, Y.
    Hartmann, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (01): : 20 - 25
  • [28] Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries
    Wall, Kristin M.
    Rida, Wasima
    Haddad, Lisa B.
    Kamali, Anatoli
    Karita, Etienne
    Lakhi, Shabir
    Kilembe, William
    Allen, Susan
    Inambao, Mubiana
    Yang, Annie H.
    Latka, Mary H.
    Anzala, Omu
    Sanders, Eduard J.
    Bekker, Linda-Gail
    Edward, Vinodh A.
    Price, Matt A.
    EPIDEMIOLOGY, 2017, 28 (02) : 224 - 232
  • [29] Regulatory T Cell Expansion and Immune Activation during Untreated HIV Type 1 Infection Are Associated with Disease Progression
    Cao, Weiwei
    Jamieson, Beth D.
    Hultin, Lance E.
    Hultin, Patricia M.
    Detels, Roger
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (02) : 183 - 191
  • [30] PLATELET DERIVED MICROPARTICLES, AGGREGATES AND MARKERS OF IMMUNE ACTIVATION AND DISEASE PROGRESSION IN HIV INFECTED TREATMENT NAIVE ASYMPTOMATIC INDIVIDUALS
    Nkambule, B.
    Davison, G.
    Ipp, H.
    HAEMATOLOGICA, 2016, 101 : 311 - 312